NO944930L - Hemming av dysfunksjonell uterin blödning - Google Patents
Hemming av dysfunksjonell uterin blödningInfo
- Publication number
- NO944930L NO944930L NO944930A NO944930A NO944930L NO 944930 L NO944930 L NO 944930L NO 944930 A NO944930 A NO 944930A NO 944930 A NO944930 A NO 944930A NO 944930 L NO944930 L NO 944930L
- Authority
- NO
- Norway
- Prior art keywords
- uterine bleeding
- dysfunctional uterine
- inhibition
- och2ch2
- piperidone
- Prior art date
Links
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 title abstract 2
- 206010027514 Metrorrhagia Diseases 0.000 title abstract 2
- 230000005764 inhibitory process Effects 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical group O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 abstract 1
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical group O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/171,391 US5446053A (en) | 1993-12-21 | 1993-12-21 | Methods of inhibiting dysfunctional uterine bleeding |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO944930D0 NO944930D0 (no) | 1994-12-19 |
| NO944930L true NO944930L (no) | 1995-06-22 |
Family
ID=22623570
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO944930A NO944930L (no) | 1993-12-21 | 1994-12-19 | Hemming av dysfunksjonell uterin blödning |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US5446053A (es) |
| EP (1) | EP0659417B1 (es) |
| JP (1) | JPH07215858A (es) |
| KR (1) | KR950016726A (es) |
| CN (1) | CN1109752A (es) |
| AT (1) | ATE168887T1 (es) |
| AU (1) | AU692490B2 (es) |
| CA (1) | CA2138510A1 (es) |
| CZ (1) | CZ321094A3 (es) |
| DE (1) | DE69412049T2 (es) |
| DK (1) | DK0659417T3 (es) |
| ES (1) | ES2119094T3 (es) |
| GR (1) | GR3027706T3 (es) |
| HU (1) | HUT71469A (es) |
| IL (1) | IL112037A (es) |
| NO (1) | NO944930L (es) |
| NZ (1) | NZ270167A (es) |
| PH (1) | PH31099A (es) |
| RU (1) | RU94044456A (es) |
| ZA (1) | ZA9410080B (es) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5811447A (en) | 1993-01-28 | 1998-09-22 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5770609A (en) | 1993-01-28 | 1998-06-23 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
| US6251920B1 (en) | 1993-05-13 | 2001-06-26 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies |
| US5847007A (en) | 1993-05-13 | 1998-12-08 | Neorx Corporation | Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells |
| US6491938B2 (en) | 1993-05-13 | 2002-12-10 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
| US5595722A (en) | 1993-01-28 | 1997-01-21 | Neorx Corporation | Method for identifying an agent which increases TGF-beta levels |
| US6197789B1 (en) | 1995-06-07 | 2001-03-06 | Neorx Corporation | Prevention and treatment of cardiovascular pathologies with tamoxifen analogues |
| US5856340A (en) * | 1995-02-28 | 1999-01-05 | Eli Lilly And Company | Method of treating estrogen dependent cancers |
| IL120266A (en) | 1996-02-28 | 2005-05-17 | Pfizer | Use of estrogen antagonists and estrogen agonists in the preparation of medicaments for inhibiting pathological conditions |
| TW442286B (en) * | 1996-02-28 | 2001-06-23 | Pfizer | New therapeutic uses of estrogen agonists |
| WO1998046588A2 (en) * | 1997-04-11 | 1998-10-22 | Neorx Corporation | Compounds and therapies for the prevention of vascular and non-vascular pathologies |
| US6054446A (en) | 1997-12-24 | 2000-04-25 | Sri International | Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use |
| WO2000030684A1 (fr) * | 1998-11-26 | 2000-06-02 | Teikoku Hormone Mfg. Co., Ltd. | Compositions medicamenteuses a administration periodique |
| CN1250563C (zh) | 1999-05-04 | 2006-04-12 | 斯特拉坎有限公司 | 雄激素糖苷及其产生雄性征的活性 |
| IN191020B (es) | 2000-03-28 | 2003-09-13 | Dabur Res Foundation | |
| JP2004531559A (ja) * | 2001-05-22 | 2004-10-14 | イーライ・リリー・アンド・カンパニー | エストロゲン欠乏または内因性エストロゲンに対する異常な生理反応に関連する疾患を抑制するためのテトラヒドロキノリン誘導体 |
| US7056931B2 (en) * | 2001-05-22 | 2006-06-06 | Eli Lilly And Company | 2-substituted 1,2,3,4-tetrahydroquinolines and derivatives thereof, compositions and methods |
| JP2005535623A (ja) * | 2002-06-25 | 2005-11-24 | ワイス | ホルモン関連症状の治療における、チオ−オキシインドール誘導体の使用 |
| KR102295878B1 (ko) | 2021-06-16 | 2021-08-31 | 최경선 | 셀프용 등 지압기 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4133814A (en) * | 1975-10-28 | 1979-01-09 | Eli Lilly And Company | 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents |
| US4380635A (en) * | 1981-04-03 | 1983-04-19 | Eli Lilly And Company | Synthesis of acylated benzothiophenes |
| US4418068A (en) * | 1981-04-03 | 1983-11-29 | Eli Lilly And Company | Antiestrogenic and antiandrugenic benzothiophenes |
| US4859585A (en) * | 1986-04-17 | 1989-08-22 | Trustees Of Tufts College | In-vitro methods for identifying compositions which are agonists and antagonists of estrogens |
| US5075321A (en) * | 1987-03-24 | 1991-12-24 | University Of Pennsylvania | Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes |
| US5395842A (en) * | 1988-10-31 | 1995-03-07 | Endorecherche Inc. | Anti-estrogenic compounds and compositions |
| JP3157882B2 (ja) * | 1991-11-15 | 2001-04-16 | 帝国臓器製薬株式会社 | 新規なベンゾチオフエン誘導体 |
-
1993
- 1993-12-21 US US08/171,391 patent/US5446053A/en not_active Expired - Lifetime
-
1994
- 1994-12-19 NZ NZ270167A patent/NZ270167A/xx unknown
- 1994-12-19 KR KR1019940034917A patent/KR950016726A/ko not_active Application Discontinuation
- 1994-12-19 DK DK94309475T patent/DK0659417T3/da active
- 1994-12-19 EP EP94309475A patent/EP0659417B1/en not_active Expired - Lifetime
- 1994-12-19 IL IL11203794A patent/IL112037A/en not_active IP Right Cessation
- 1994-12-19 PH PH49597A patent/PH31099A/en unknown
- 1994-12-19 CN CN94119734A patent/CN1109752A/zh active Pending
- 1994-12-19 DE DE69412049T patent/DE69412049T2/de not_active Expired - Fee Related
- 1994-12-19 RU RU94044456/14A patent/RU94044456A/ru unknown
- 1994-12-19 CA CA002138510A patent/CA2138510A1/en not_active Abandoned
- 1994-12-19 NO NO944930A patent/NO944930L/no unknown
- 1994-12-19 JP JP6314590A patent/JPH07215858A/ja active Pending
- 1994-12-19 ES ES94309475T patent/ES2119094T3/es not_active Expired - Lifetime
- 1994-12-19 ZA ZA9410080A patent/ZA9410080B/xx unknown
- 1994-12-19 HU HU9403663A patent/HUT71469A/hu unknown
- 1994-12-19 CZ CZ943210A patent/CZ321094A3/cs unknown
- 1994-12-19 AT AT94309475T patent/ATE168887T1/de not_active IP Right Cessation
- 1994-12-19 AU AU81561/94A patent/AU692490B2/en not_active Ceased
-
1995
- 1995-04-14 US US08/422,388 patent/US5552416A/en not_active Expired - Lifetime
-
1998
- 1998-08-20 GR GR980401883T patent/GR3027706T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH31099A (en) | 1998-02-05 |
| DE69412049T2 (de) | 1999-01-14 |
| EP0659417B1 (en) | 1998-07-29 |
| GR3027706T3 (en) | 1998-11-30 |
| AU692490B2 (en) | 1998-06-11 |
| ATE168887T1 (de) | 1998-08-15 |
| KR950016726A (ko) | 1995-07-20 |
| NO944930D0 (no) | 1994-12-19 |
| US5446053A (en) | 1995-08-29 |
| CZ321094A3 (en) | 1995-08-16 |
| US5552416A (en) | 1996-09-03 |
| EP0659417A2 (en) | 1995-06-28 |
| DE69412049D1 (de) | 1998-09-03 |
| ZA9410080B (en) | 1996-06-19 |
| AU8156194A (en) | 1995-06-29 |
| NZ270167A (en) | 1997-08-22 |
| HUT71469A (en) | 1995-11-28 |
| JPH07215858A (ja) | 1995-08-15 |
| CN1109752A (zh) | 1995-10-11 |
| HU9403663D0 (en) | 1995-02-28 |
| RU94044456A (ru) | 1996-10-10 |
| DK0659417T3 (da) | 1998-12-07 |
| ES2119094T3 (es) | 1998-10-01 |
| IL112037A0 (en) | 1995-03-15 |
| EP0659417A3 (en) | 1995-09-06 |
| CA2138510A1 (en) | 1995-06-22 |
| IL112037A (en) | 1999-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO944930L (no) | Hemming av dysfunksjonell uterin blödning | |
| NO944911L (no) | Ikke-peptid-takykininreseptorantagonister | |
| MY132056A (en) | Methods of inhibiting physiological conditions associated with an excess of neuropeptide y. | |
| MX9602837A (es) | Composiciones cosmeticas o farmaceuticas que contienen mangiferina o sus derivados. | |
| NO944927L (no) | Fremgangsmåte for inhibering av pulmonar hypertensiv sykdom | |
| NO944914L (no) | Fremgangsmåte for å inhibere autoimmunsykdommer | |
| NO944934L (no) | Hemming av vasomotoriske symptomer og tilhörende psykologiske forstyrrelser i forbindelse med post-menopausalt syndrom | |
| NO944919L (no) | Fremgangsmåte for å inhibere atrofi av huden eller vagina | |
| DK0652005T3 (da) | Fremgangsmåder til inhibering af endometriose | |
| UA32427C2 (uk) | Застосування бензотіофенів або їх фармацевтично прийнятних солей або сольватів для інгібування ангіогенезу і/або ангіогенних захворювань | |
| NO944926L (no) | Fremgangsmåter for å inhibere myeloperoksidaseaktivitet | |
| TW360652B (en) | Acryloyl substituted disstamycin derivatives, process for preparing them, and pharmaceutical composition comprising them | |
| NO944924L (no) | Fremgangsmåter for inhibering av Turner's syndrom | |
| NZ516100A (en) | Streptogramin derivatives, preparation and compositions containing them | |
| NO944933L (no) | Fremgangsmåte for å inhibere sykdomstilstander i brystet | |
| NO972887L (no) | Piperidineddiksyrederivater anvendelige som fibrinogen-antagonistmiddel | |
| NO944923L (no) | Hemming av vektökning eller indusering av vekttap | |
| MY132085A (en) | Methods for inhibiting bone prosthesis degeneration | |
| NO975580L (no) | Fremgangsmåte for å inhibere melanom | |
| NO944577L (no) | Hemming av effekten av amyloidogene proteiner | |
| NO981578L (no) | FremgangsmÕte for hemming av plasminogenaktivatorhemmer I | |
| NO971794L (no) | Fremgangsmåte for hemming av tilstander forbundet med bradykinin | |
| NO944909L (no) | Fremgangsmåter for inhibering av mannlig infertilitet | |
| NO973609L (no) | Fremgangsmåte for å inhibere effektene av IL-6 | |
| NO973103L (no) | Fremgangsmåte for inhibering av veksthormoneffekter |